The University of Birmingham has developed a state-of-the-art GMP Manufacturing Suite for Advanced Therapies development.
Licensed by the MHRA for the manufacture of Advanced Therapy Medicinal Products (ATMP) for clinical use, experts within the Advanced Therapies Facility (ATF) also benefit from a Specials licence allowing the manufacture of products for use in selected patients outside of clinical trial settings. The ATF is situated adjacent to the NIHR/Wellcome Trust Clinical Research Facility, where manufactured products can be administered to patients in an appropriate clinical environment.
Through collaborative research with partners and clients the Facility strives to further the development of effective cell-, tissue- and gene-based therapies, in a predominantly clinical trial environment.
